SCHEMBL25560778

SCHEMBL25560778

CC(C)=CCC/C(C)=C\Cc1c(O)cc(CO)c(C(=O)O)c1O

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC6A3 Q01959 1/20 0.74
▸ TRPM7 Q96QT4 1/20 0.74
▸ DAGLA Q9Y4D2 1/20 0.74
▸ CNR2 P34972 1/20 0.72
▸ BACE1 P56817 4/20 0.72
▸ APP P05067 3/20 0.72
▸ PTPN1 P18031 2/20 0.72
▸ PTGES O14684 1/20 0.67
▸ ALOX5 P09917 1/20 0.67
▸ PTGS1 P23219 1/20 0.67
▸ PTGS2 P35354 1/20 0.67
▸ MAOB P27338 4/20 0.65
▸ PPARG P37231 2/20 0.56
▸ PPARD Q03181 1/20 0.56
▸ PPARA Q07869 1/20 0.56
▸ DNMT1 P26358 1/20 0.56
▸ SIRT5 Q9NXA8 1/20 0.56
▸ CTSL P07711 1/20 0.55
▸ MGAM O43451 1/20 0.54
▸ OSBP P22059 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25560668 0.91 SLC6A3 (0.79) SLC6A3TRPM7DAGLACNR2BACE1
SCHEMBL23523461 0.89 SLC6A3 (0.72) SLC6A3TRPM7DAGLACNR2BACE1
SCHEMBL23523459 0.89 SLC6A3 (0.72) SLC6A3TRPM7DAGLACNR2BACE1
SCHEMBL25560796 0.89 SLC6A3 (0.82) SLC6A3TRPM7DAGLACNR2BACE1
SCHEMBL19714693 0.88 SLC6A3 (0.85) SLC6A3TRPM7DAGLACNR2BACE1
SCHEMBL23523284 0.88 SLC6A3 (0.78) SLC6A3TRPM7DAGLACNR2BACE1
SCHEMBL23523285 0.88 SLC6A3 (0.78) SLC6A3TRPM7DAGLACNR2BACE1
SCHEMBL13214111 0.88 SLC6A3 (0.85) SLC6A3TRPM7DAGLACNR2BACE1
SCHEMBL29530411 0.88 SLC6A3 (0.85) SLC6A3TRPM7DAGLACNR2BACE1
SCHEMBL23523640 0.88 SLC6A3 (0.84) SLC6A3TRPM7DAGLACNR2BACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230165807-A1 COMPOSITIONS INCLUDING TERPENES, CANNABINOID OILS, OR FLAVONOIDS AND USES THEREOF CALIBRATED THERAPEUTICS, LLC 2023-06-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230165807-A1 COMPOSITIONS INCLUDING TERPENES, CANNABINOID OILS, OR FLAVONOIDS AND USES THEREOF CNR2, CNR1, FAAH SLC6A3 2567/4885TRPM7 1845/4885DAGLA 17/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback